South Korea shows a remarkable rapid increase in lifespan in recent decades.
Introduction
datasets taken from the Korean Statistical Information Service (KOSIS, http://kosis.kr/eng), we evaluate current trends in female lifespan for South Korea over three recent decades, from 1987 to 2016, and estimate coming trends in female lifespan until 2030. This analysis for South Korea is compared with that for Japan, France, Australia, Switzerland, UK, Sweden, and USA, which are the leading countries in longevity (Kontis et al. 2017) .
The survival curve is described as the survival rate, s(x), as a function of age, x.
Mathematically the mortality rate (equivalently the hazard function or the force of mortality), μ (x) = −dln(s(x))/dx, is computed from the derivative of the survival rate with respect to age. The important feature of s(x) is that s(x) always monotonically decreases with age from 1 to 0. To describe the human survival curves, a modified stretched exponential function has been developed as a form of s(x) = exp(-(x/α)
where the stretched exponent, β (x), is defined as β (x) = ln [-ln(s(x) )]/ln(x/α) and the characteristic life, α , is given at s(α) = exp(-1) that is practically obtained at the interception point between s(x) and s(α) = exp(-1) (Weon and Je 2009; 2011; 2012; Weon 2015) . The characteristic life is a good alternative to the life expectancy at birth, ε (Wrycza and Baudisch 2014; Weon and Je 2012) . The age dependence of the stretched exponent is the critical feature of the modified stretched exponential function, which is fundamentally different from the classical stretched exponential (equivalently the Kohlrausch-Williams-Watts (Kohlrausch 1854; Williams and Watts 1970) or the Weibull (Weibull 1951) ) function (Weon and Je 2009; 2011; 2012; Weon 2015) . The characteristic life and the stretched exponent are useful to respectively describe the scale effect (associated with 'living longer', characterized by α ) and the shape effect (associated with 'growing older', characterized by β (x)) of the individual survival curve (Weon and Je 2012) . To describe the β (x) patterns at very old ages, the quadratic formula of β (x) = β 0 + β 1 x + β 2 x 2 is applicable (Weon and Je 2009; Weon 2015) . The quadratic patterns in β (x) certainly lead to the occurrence of the (mathematical) maximum lifespan, ω , which is obtained at the age for β (x) = -xln(x/α) dβ(x)/dx by the constraint of ds(x)/dx → 0 (Weon and Je 2009 ). This methodology is beneficial in modeling the human mortality curves in very old age (Weon 2015) .
In this study, we evaluate the survival curves for South Korean female in the most 
Results and Discussion
The term 'lifespan' describes how long an individual can live and the (observed) maximum lifespan is the age reached by the longest-lived member of a species, while the life expectancy is a population-based estimate of expected duration of life for individuals at any age, based on a statistical life table (Olshansky 2016) . Our methodology enables us to estimate the characteristic life, α , and the (mathematical) maximum lifespan, ω , as good measures of the human lifespan.
-6 - The modified stretched exponential function was successfully applicable to the survival curves and to the age-dependent stretched exponents, β (x), (marked by the shape effect) in Figs. 1c & 1d ., respectively for all ages (Fig. 1c) and for old ages over 60 years (Fig. 1d) . Most remarkably, the β (x) curve smoothly varies with age at old ages over 60 years and the old-age β (x) patterns over 90 years can be depicted with the quadratic function of age.
Typically, the β (x) patterns for long-lived populations show the phase transition with age: β (x) increases with age at x < α and decreases with age at x > α ( (Fig. 2) , the survival curves become increasingly concentrated at very old ages, corresponding to the retangularization of survival curves (Fries 1980; Weon and Je 2011) . This tendency is relevant to the compression of morbidity, which becomes more important in very old age and would be responsible for the concentration of the very old populations (Weon 2015) .
The detailed comparison in the increase rate of the characteristic life, α , for South Korea with that for major industrialized countries is shown in Fig. 3 . The increase rate in α was obtained from Fig. 1b contributions to the remarkable improvements in health for South Korea (Yang et al. 2010 ). The rapid increases in life expectancy in South Korea could be mostly achieved by reductions in infant mortality and in decreases related to infections and blood pressure (Yang et al. 2010 ). More recent gains in South Korea have been largely due to postponement of death from chronic diseases (Yang et al. 2010 ). These gains were mainly due to broad-based inclusive improvements in economic status and social capital (including education), which improved childhood and adolescent nutrition (NCD-RisC 2016a), expanded access to primary and secondary health care, and facilitated rapid scale-up of new medical technologies (Yang et al. 2010) . South
Korea has also maintained lower body-mass index and blood pressure than other industrialized countries (NCD-RisC 2016b; 2017) , and lower smoking in women.
Additionally, South Korea might have lower health inequalities (for cancer and cardiovascular disease mortality, and for self-reported health status) than some of their western counterparts, especially for women (Di Cesare et al. 2013; OECD 2015; Khang et al. 2016 ). The death rates from all causes in South Korea decreased significantly in both genders in the last three decades except for a period following the economic crisis in the late 1990s (Lim et al. 2014) . Looking at the trends in infectious disease mortality for South Korea, 1983 Korea, -2015 , infant mortality caused by infectious diseases has substantially decreased, while death rates from infectious disease for elderly populations with lower education levels and subgroups susceptible to respiratory infections and sepsis has not decreased overall (Choe et al. 2018 ).
The lifespan trends for South Korean female may give a clue for the fundamental question about how human aging evolves or whether there is a limit to human lifespan (Carnes and Witten 2014; Dong et al. 2016; Olshansky 2016; Newman and Easteal 2017; Marck et al. 2017) . The heterogeneity in population and the dynamics of 
